Celltrion targets $3.46 bn in sales this year on biosimilars
S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar
Celltrion gets US FDA approval for new biosimilar for autoimmune disease treatment
Dr. Ghai Honored for Exceptional Contributions to Medicine in Jalandhar
Sharad Kelkar: ‘Doctors’ might inspire some to pursue medicine
